Association of serum growth differentiation factor 15 level with acute ischemic stroke in a Chinese population

References

• Fisher M. Introducing focused updates in cerebrovascular disease. Stroke. 2017;48(10):2653–2653.
   PubMed Web of Science ®Google Scholar
• Ustrell-Roig X, Serena-Leal J. Stroke. Diagnosis and therapeutic management of cerebrovascular disease. Revista Espanola De Cardiologia. 2007;60(7):753–769.
   PubMed Web of Science ®Google Scholar
• Wang YJ, Liu M, Pu CQ. 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack: Compiled by the Chinese Society of Neurology, Cerebrovascular Disease Group. Int J Stroke. 2017;12(3):302–320.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update a report from the American Heart Association. Circulation. 2017;135(10):E146–E603.
   PubMed Web of Science ®Google Scholar
• Whiteley W, Chong WL, Sengupta A, et al. Blood markers for the prognosis of ischemic stroke a systematic review. Stroke. 2009;40(5):E380–E389.
   PubMed Web of Science ®Google Scholar
• Atzeni F, Sitia S, Tomasoni L, et al. Preclinical atherosclerosis in rheumatoid arthritis: from endothelial dysfunction to atherosclerosis. Rheumatology. 2011;50:103–103.
   Web of Science ®Google Scholar
• Szocs K. Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen Physiol Biophys. 2004;23(3):265–295.
   PubMed Web of Science ®Google Scholar
• Bootcov MR, Bauskin AR, Valenzuela SM, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA. 1997;94(21):11514–11519.
   PubMed Web of Science ®Google Scholar
• Xu XY, Li ZJ, Gao W. Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside. Biomarkers. 2011;16(6):466–475.
   PubMed Web of Science ®Google Scholar
• Falk M, Huhn R, Behmenburg F, et al. Biomechanical stress in myocardial infarctions: can endothelin-1 and growth differentiation factor 15 serve as immunohistochemical markers? Int J Legal Med. 2018;132(2):509–518.
   PubMed Web of Science ®Google Scholar
• Lind L, Wallentin L, Kempf T, et al. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study. Eur Heart J. 2009;30(19):2346–2353.
   PubMed Web of Science ®Google Scholar
• Goliasch G, Kleber ME, Richter B, et al. Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score. Eur Heart J. 2012;33(18):2282–2289.
   PubMed Web of Science ®Google Scholar
• Bonaca MP, Morrow DA, Braunwald E, et al. Growth differentiation Factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome observations from PROVE IT-TIMI 22. Arterioscler Thromb Vasc Biol. 2011;31(1):203–210.
   PubMed Web of Science ®Google Scholar
• Cotter G, Voors AA, Prescott MF, et al. Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study. Eur J Heart Fail. 2015;17(11):1133–1143.
   PubMed Web of Science ®Google Scholar
• Fisher M, Moores L, Alsharif MN, et al. Definition and implications of the preventable stroke. JAMA Neurol. 2016;73(2):186–189.
   PubMed Web of Science ®Google Scholar
• Afridi I, Canny J, Yao CH, et al. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21(11):1983–1992.
   PubMed Web of Science ®Google Scholar
• Puavilai G, Chanprasertyotin S, Sriphrapradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO Consultation criteria, and 1985 WHO criteria. Diabetes Res Clin Pract. 1999;44(1):21–26.
   PubMed Web of Science ®Google Scholar
• Giovino GA, Biener L, Hartman AM, et al. Monitoring the tobacco use epidemic I. Overview: Optimizing measurement to facilitate change. Prev Med. 2009;48(1):S4–S10.
   PubMedGoogle Scholar
• Witkiewitz K, Hallgren KA, Kranzler HR, et al. Clinical validation of reduced alcohol consumption after treatment for alcohol dependence using the World Health Organization Risk Drinking Levels. Alcohol Clin Exp Res. 2017;41(1):179–186.
   PubMed Web of Science ®Google Scholar
• Pant S, Deshmukh A, GuruMurthy GS, et al. Inflammation and atherosclerosis-revisited. J Cardiovasc Pharmacol Ther. 2014;19(2):170–178.
   PubMed Web of Science ®Google Scholar
• Donnan GA, Fisher M, Macleod M, et al. Stroke. Lancet. 2008;371(9624):1612–1623.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Akesson A, Wolk A. Primary prevention of stroke by a healthy lifestyle in a high-risk group. Neurology. 2015;84(22):2224–2228.
   PubMed Web of Science ®Google Scholar
• Power A. Stroke in Dialysis and Chronic Kidney Disease. Blood Purif. 2013;36(3-4):179–183.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Tomitori H, Machi Y, et al. Acrolein, IL-6 and CRP as markers of silent brain infarction. Atherosclerosis. 2009;203(2):557–562.
   PubMed Web of Science ®Google Scholar
• Breit SN, Johnen H, Cook AD, et al. The TGF-beta superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth Factors. 2011;29(5):187–195.
   PubMed Web of Science ®Google Scholar
• Wiklund FE, Bennet AM, Magnusson PKE, et al. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell. 2010;9(6):1057–1064.
   PubMed Web of Science ®Google Scholar
• Kempf T, Eden M, Strelau J, et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circulation Res. 2006;98(3):351–360.
   PubMed Web of Science ®Google Scholar
• Katan Copeptin: a novel, independent prognostic marker in patients with ischemic stroke (vol 66, pg 799, 2009). Ann Neurol. 2010;67(2):278–281.
   Web of Science ®Google Scholar
• Groeschel K, Schnaudigel S, Edelmann F, et al. Growth-differentiation factor-15 and functional outcome after acute ischemic stroke. J Neurol. 2012;259(8):1574–1579.
   PubMed Web of Science ®Google Scholar
• Worthmann H, Kempf T, Widera C, et al. Growth differentiation Factor 15 plasma levels and outcome after ischemic stroke. Cerebrovasc Dis. 2011;32(1):72–78.
   PubMed Web of Science ®Google Scholar
• Schindowski K, von Bohlen und Halbach O, Strelau J, et al. Regulation of GDF-15, a distant TGF-beta superfamily member, in a mouse model of cerebral ischemia. Cell Tissue Res. 2011;343(2):399–409.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB, D’Agostino RB, Jr, et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–172.
   PubMed Web of Science ®Google Scholar
• Elkind MSV, Tai W, Coates K, et al. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A(2), and outcome after ischemic stroke. Arch Intern Med. 2006;166(19):2073–2080.
   PubMedGoogle Scholar